title: Benefits of vascular normalization are dose and time dependent--letter.
authors.affiliation: Authors' Affiliation: Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Yuhui
authors.initials: Y
authors.lastname: Huang
authors.forename: Triantafyllos
authors.initials: T
authors.lastname: Stylianopoulos
authors.forename: Dan G
authors.initials: DG
authors.lastname: Duda
authors.forename: Dai
authors.initials: D
authors.lastname: Fukumura
authors.forename: Rakesh K
authors.initials: RK
authors.lastname: Jain
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000493:pharmacokinetics* / Q000494:pharmacology*; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism*; D008297:Male; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G